K-numberK243292
Device namebrAIn™ Shoulder Positioning
ApplicantAvatar Medical
Product codeLLZ
Device classClass II
Decision dateMar 20, 2025
DecisionSubstantially Equivalent
Regulation892.2050
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

brAIn™ Shoulder Positioning is a cloud-based software tool that assists shoulder surgeons in preoperative planning and visualization of primary total shoulder replacement surgeries. It uses CT-scan imaging to automatically segment shoulder anatomy (scapula and humerus) via machine learning, displays interactive 3D reconstructions, allows surgeons to position anatomical and reverse implants, and generates a planning report with measurements and visual documentation.

Technological characteristics

The subject device performs automatic segmentation of shoulder anatomy, whereas the predicate device required manual segmentation. brAIn™ includes semi-automatic landmark measurements and implant placement, displays both axial and coronal 2D DICOM views (vs. axial-only in predicate), shows soft tissue visualization in the 3D viewer, and captures patient age, height, and weight in addition to predicate information fields. The underlying principles, web-based architecture, CT-scan input, pre-operative use timing, and implant types planned remain equivalent.

Test standards cited

ANSI AAMI IEC 62304:2006/A1:2016 (Medical device software – Software life cycle processes); FDA Guidance for the Content of Premarket Submissions for Software Contained in Medical Devices; FDA Content of Premarket Submission for Management of Cybersecurity in Medical Devices.

Substantial equivalence argument

The subject device has the same intended use as the predicate (preoperative planning and visualization for total shoulder replacement) and uses identical imaging input (CT-scans) with the same implant types and patient population. Although brAIn™ employs automatic rather than manual segmentation and includes additional measurement and visualization features, validation testing demonstrates that the automatic segmentation meets a Dice Similarity Coefficient of ≥0.95 versus manual segmentation, measurement accuracy matches the predicate's performance, and landmark positioning achieves equivalent accuracy. These technological improvements do not raise new safety or effectiveness concerns—they represent enhancements that maintain or exceed predicate performance without introducing new risks.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →